ARO-HIF2

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameARO-HIF2
Drug Alias NameHIF2-RNAiARO-HIF2
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionEndothelial PAS domain-containing protein 1 inhibitorsRNA interference
TargetsEndothelial PAS domain-containing protein 1
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArrowhead Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesArrowhead Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A